Janus Henderson Group PLC Abcam PLC Transaction History

Janus Henderson Group PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $32.3 Million - $36.6 Million	-1,500,659 Reduced 37.94%	2,454,599 $55.5 Million
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $6.6 Million - $12.8 Million	522,633 Added 15.23%	3,955,258 $96.8 Million
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $30.2 Million - $39.8 Million	2,329,781 Added 211.25%	3,432,625 $46.2 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $1.02 Million - $1.25 Million	73,417 Added 7.13%	1,102,844 $17.2 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $83,112 - $104,201	6,221 Added 0.61%	1,029,427 $15.4 Million
Q2 2022 Aug 15, 2022	SELL	$12.69 - $19.25 $233,229 - $353,795	-18,379 Reduced 1.76%	1,023,206 $14.8 Million
Q1 2022 May 16, 2022	SELL	$15.5 - $23.89 $179,676 - $276,932	-11,592 Reduced 1.1%	1,041,585 $19.1 Million
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $236,952 - $281,884	11,824 Added 1.14%	1,053,177 $24.8 Million
Q3 2021 Nov 16, 2021	BUY	$17.38 - $21.54 $736,407 - $912,671	42,371 Added 4.24%	1,041,353 $21.1 Million
Q2 2021 Aug 16, 2021	SELL	$18.47 - $22.11 $2.83 Million - $3.39 Million	-153,182 Reduced 13.3%	998,982 $19 Million
Q1 2021 May 17, 2021	BUY	$19.22 - $24.3 $1.84 Million - $2.32 Million	95,648 Added 9.05%	1,152,164 $22.1 Million
Q4 2020 Feb 16, 2021	BUY	$18.2 - $22.45 $19.2 Million - $23.7 Million	1,056,516 New	1,056,516 $22.8 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.